- RS 504393
-
- $43.00 / 1mg
-
2024-11-19
- CAS:300816-15-3
- Min. Order:
- Purity: 98.64%
- Supply Ability: 10g
- RS 504393
-
- $0.00 / 1kg
-
2022-09-08
- CAS:300816-15-3
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1Ton
- RS 504393
-
- $5.50 / 1KG
-
2020-01-13
- CAS:300816-15-3
- Min. Order: 1IU
- Purity: 98%min
- Supply Ability: 1kg-100kg
|
| | RS 504393 Basic information |
| Product Name: | RS 504393 | | Synonyms: | Spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, 6-Methyl-1'-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethyl]-;6-Methyl-1'-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidi;6-Methyl-1'-(2-(5-Methyl-2-phenyloxazol-4-yl)ethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one;6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro-[benzo[d][1,3]oxazine-4,4'-piperidin]-2(;6-Methyl-1'-(2-(5-methyl-2-phenyloxazol-4-yl)ethyl)spiro-[benzo[d][1,3]oxazine-4,4'-piperidin];RS 504393;6-Methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one;RS-504393; RS504393 | | CAS: | 300816-15-3 | | MF: | C25H27N3O3 | | MW: | 417.5 | | EINECS: | | | Product Categories: | | | Mol File: | 300816-15-3.mol |  |
| | RS 504393 Chemical Properties |
| density | 1.28 | | storage temp. | 2-8°C | | solubility | DMSO: soluble1mg/mL, clear (warmed) | | form | powder | | color | white to beige |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 |
| | RS 504393 Usage And Synthesis |
| Uses | RS 504393 is a small molecule antagonist at the CC chemokine receptor 2. | | Uses | RS504393 has been used in mass spectrometry. | | Definition | ChEBI: 6-methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-2-spiro[1H-3,1-benzoxazine-4,4'-piperidine]one is a member of 1,3-oxazoles. | | Biological Activity | Extremely selective CCR2 chemokine receptor antagonist (IC 50 values are 98 nM and > 100 μ M for inhibition of human recombinant CCR2b and CCR1 receptors respectively). Inhibits MCP-1 chemotaxis (IC 50 = 330 nM) and ischemia-reperfusion injury in kidneys. | | Biochem/physiol Actions | RS504393 is a highly selective CCR2 chemokine receptor antagonist. RS504393 inhibits MCP-1 chemotaxis and ischemia-reperfusion injury in kidneys. | | storage | Store at +4°C |
| | RS 504393 Preparation Products And Raw materials |
|